We are live on ! Find out more
NVOS

Novo Integrated Sciences, Inc. Common Stock
NVOS

Delisted

NVOS was delisted on the 5th of November, 2024.

Back to rankings

8 hedge funds and large institutions have $570K invested in Novo Integrated Sciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

33% more funds holding

Funds holding: 6 → 8 (+2)

23% less capital invested

Capital invested by funds: $738K → $570K (-$168K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$21.7K
2
TSS
Two Sigma Securities
New York
+$20.8K
3
TRCT
Tower Research Capital (TRC)
New York
+$5.2K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$26K
2
BlackRock
BlackRock
New York
-$12.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$358K – – –
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$121K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$33K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$19K +$21.7K +1,380 New
TSS
5
Two Sigma Securities
New York
$18K +$20.8K +1,318 New
BlackRock
6
BlackRock
New York
$16K -$12.9K -817 -43%
TRCT
7
Tower Research Capital (TRC)
New York
$5K +$5.2K +330 New
Millennium Management
8
Millennium Management
New York
– -$26K -1,411 Closed

NVOS Hedge Fund Activity: Q4 2021 in Review

8 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q4 2021, worth a combined $570K — down 23% from $738K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NVOS positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $21.7K. The largest seller was Millennium Management, exiting entirely with an estimated $26K sold.

  • 8 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q4 2021, up from 6 in Q3 2021.
  • Funds reported $570K of Novo Integrated Sciences, Inc. Common Stock stock for Q4 2021, down 23% quarter-over-quarter.
  • 3 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q4 2021 and 1 closed out, a net change of +2 holders.
  • The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q4 2021 was Renaissance Technologies, an estimated $21.7K added.
  • The largest Novo Integrated Sciences, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2021.